Mr Zohar Yahalom > Herzog Fox & Neeman > Tel Aviv, Israel > Lawyer Profile

Herzog Fox & Neeman
Herzog Tower
6 Yitzhak Sadeh St.
Tel Aviv 6777506
Israel

Work Department

Commercial

Position

Partner, Head of Health Technologies and Life Sciences

Career

Zohar Yahalom Heads the Firm’s Health Technologies and Life Sciences Practice. Zohar advises clients in various industries including pharmaceuticals, biotech, medical devices, clinical research, medical cannabis, veterinary medicine, dietary supplements, cosmetics, homeopathy and alternative medicine. Zohar also advises healthcare service providers and medical practitioners on all healthcare regulatory matters. Zohar is the author of numerous books and professional articles on Israeli regulations and is a lecturer at various forums including the Hebrew University of Jerusalem. Zohar is a former Legal Advisor of the Israeli Ministry of Health’s Pharmaceutical Division and Medical Technologies Administration.

Languages

Hebrew, English, Spanish

Memberships

Israel, 1997

Education

Hebrew University of Jerusalem, Israel, LL.B, 1996

Lawyer Rankings

Israel > Healthcare and life sciences

(Leading individuals)

Zohar YahalomHerzog Fox & Neeman

Neta Dorfman-Raviv and Zohar Yahalom jointly lead the ‘efficient, effective, knowledgeable and kind’ team at Herzog Fox & Neeman. The practice displays deep bench strength across a wide variety of areas, advising a varied client base of both state-owned and private hospitals and research institutions on the use of health data and hospital spin-offs. Yahalom is known for his expansive regulatory knowledge, regularly assisting companies in the pharma, biotech, and medical device spaces with reimbursement related matters, and generic competition, and Dorfman-Raviv primarily acts for hospitals, Israeli health maintenance organisations (HMO), and insurers in their interactions with government entities, including the Ministry of Health. Dan Sharot is well-versed in IP licensing issues, regularly advising on medical equipment purchasing, research collaboration, and patent licence agreements.